← back to search

Rory Stark

Cancer Research UK ·
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Genomics and Chromatin Dynamics, RNA Research and Splicing, Prostate Cancer Treatment and Research, and Estrogen and related hormone effects.
h-index
22
citations
10,555
works
72
NIH funding
primary concept
email

Recent publications

Smoking-associated gene expression alterations in nasal epithelium reveal immune impairment linked to lung cancer risk
Genome Medicine 2024cited by 21position: middledoi
<i>ZFTA</i> Translocations Constitute Ependymoma Chromatin Remodeling and Transcription Factors
Cancer Discovery 2021cited by 86position: middledoi
Normalizing ChIP and ATAC sequencing data for differential analysis
Faculty of 1000 Research Ltd 2020cited by 1position: firstdoi
RNA sequencing: the teenage years
Nature Reviews Genetics 2019cited by 2,018position: firstdoi
Independence of HIF1a and androgen signaling pathways in prostate cancer
bioRxiv (Cold Spring Harbor Laboratory) 2019cited by 2position: middledoi
Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144]
EBioMedicine 2017cited by 3position: middledoi
Progesterone receptor modulates ERα action in breast cancer
Nature 2015cited by 662position: middledoi
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
EBioMedicine 2015cited by 323position: middledoi
Abstract B133: Regulation of the androgen receptor function by a metabolic kinase in prostate cancer.
Molecular Cancer Therapeutics 2013cited by 0position: middledoi
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Nature 2012cited by 2,352position: middledoi
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
Lecture notes in computer science 2012cited by 1,514position: firstdoi
Independence of Repressive Histone Marks and Chromatin Compaction during Senescent Heterochromatic Layer Formation
Molecular Cell 2012cited by 312position: middledoi
Latent Regulatory Potential of Human-Specific Repetitive Elements
Molecular Cell 2012cited by 68position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

David E. Neal · University of Oxford4 papers (2013–2019)Ian G. Mills · University of Manchester4 papers (2013–2019)Andy G. Lynch · University of St Andrews3 papers (2013–2017)Mark Dunning · Insigneo3 papers (2012–2017)Antonio Ramos‐Montoya · Cancer Research UK Cambridge Center3 papers (2015–2019)James Hadfield · AstraZeneca (United Kingdom)3 papers (2015–2019)Jason S. Carroll · Brigham Young University2 papers (2012–2015)Carlos Caldas · Concern Foundation2 papers (2012–2015)Nimish Shah · Nirma University2 papers (2015–2017)Robert B. Russell · Heidelberg University2 papers (2015–2017) · 2 papers (2015–2017)Gordon D. Brown · University of Cape Town2 papers (2012–2015)Hisham Mohammed · Cancer Research UK Cambridge Center2 papers (2013–2015)Hayley C. Whitaker · University College London2 papers (2015–2017)Alastair Lamb · Cambridge University Hospitals NHS Foundation Trust2 papers (2015–2017)Helen Ross‐Adams · Cancer Research UK Cambridge Center2 papers (2015–2017)Henrik Grönberg · Karolinska Institutet2 papers (2015–2017)Christopher S. Cooper · University of Iowa2 papers (2015–2017)Jonathan Kay · The University of Texas Southwestern Medical Center2 papers (2015–2017)Charlie E. Massie · Cambridge University Hospitals NHS Foundation Trust2 papers (2013–2019)